Board member Rajeev Shah resigns from Black Diamond Therapeutics board effective Jan 17, 2024

Black Diamond Therapeutics, Inc.

Rajeev Shah resigned from the Board and its Audit Committee, effective immediately on January 17, 2024.
Shah had served as a director since December 2018; resignation not due to any disagreement with the Company.
No replacement director has been announced as of the filing date.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rajeev Shah

Director

BDTX · Black Diamond Therapeutics, Inc.

Effective: 2024-01-17
Filed: January 18, 2024, 6:59 PM ET

Rajeev Shah notified Black Diamond Therapeutics, Inc. (the “Company”) of his intent to resign from the Company’s Board of Directors (the “Board”), including his position as a member of the Audit Committee of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rajeev Shah resigned as Director at Black Diamond Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

Rajeev Shah notified Black Diamond Therapeutics, Inc. (the “Company”) of his intent to resign from the Company’s Board of Directors (the “Board”), including his position as a member of the Audit Committee of the Board, effective immediately.

View on SEC.gov

Black Diamond Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-004802

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.